On April 23, we suggested investors take a bullish posture on NVO, the maker of Ozempic (a popular diabetes therapy) and Wegovy (the popular weight loss drug). This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Share: Mark W. Guthner, CFA Previous Post Apple Inc: AAPLNext PostDollar General: DG You Might Also Like SpaceX | SPCX July 8, 2026 Adjust the Trade in GameStop (GME) September 6, 2018 I Do for Baidu January 30, 2019
You Might Also Like SpaceX | SPCX July 8, 2026 Adjust the Trade in GameStop (GME) September 6, 2018 I Do for Baidu January 30, 2019
